Google

By Jonah Comstock December 7, 2015
Google Life Sciences has finally gotten its new name as an independent company under the aegis of Alphabet: Verily. With the launch of a new website, the company has also clarified and cemented its mission: to bring different healthcare and technology stakeholders together to reinvent areas of healthcare. "Imagine a chemist and an engineer and a doctor and a behavioral scientist, all working...
By Brian Dolan November 11, 2015
San Francisco-based AliveCor, which offers smartphone-enabled ECG devices, has announced former Google SVP Vic Gundotra as its new CEO. Gundotra, who left Google in 2014 after eight years -- including a few heading up Google+, replaces Euan Thomson, an AliveCor board member and Khosla Ventures investor, who assumed the role of interim CEO in 2013. Gundotra becomes AliveCor's fourth CEO in almost...
By Brian Dolan October 27, 2015
Fitbit Surge The Consumer Electronics Association (CEA), which puts on the massive CES event in Las Vegas every January, just published a set of voluntary guidelines for how technology companies should approach privacy and security for personal wellness data collected by wearable devices and other connected wellness devices. The CEA said the guidelines represent a consensus among its member...
By Aditi Pai September 17, 2015
Google subsidiary Alphabet, has hired Dr. Tom Insel, former director of the National Institute of Mental Health (NIMH), to spearhead the company's mental health efforts in its life sciences division. Insel has worked as director of NIMH for 13 years before he moved to Google. In a statement about his transition, Insel said, "The GLS mission is about creating technology that can help with earlier...
By Jonah Comstock September 16, 2015
An Oscar-branded Misfit Flash device. Oscar, a small New York City-based health insurer noted for its individual focus and digital health savvy, has secured a $32.5 million investment from Google Capital, one of the search giant's two investment arms. The investment may well be strategic, according to the Wall Street Journal, which broke the story. Last April, Oscar raised $145 million in a...
By Jonah Comstock September 8, 2015
Google and Novartis are working on two smart contact lenses, and news broke this week about both of them: A new patent application sheds light on how Google might power its glucose-sensing contact lens, just a week after partner Novartis told a Swiss newspaper it was on track for human trials in 2016 of an autofocus lens for presbyopia patients. Patent applications don't always presage exactly...
By Jonah Comstock August 31, 2015
Sanofi's IBG Star connected glucometer. Google Life Science's recently-announced partnership with Dexcom (not to mention its contact lens project with Novartis) have already made it clear that diabetes is a focus for the company. Now the company is making that focus official in a new partnership with Sanofi and the Joslin Diabetes Center. "Today, we’re announcing a new partnership with Sanofi...
By Jonah Comstock August 21, 2015
Google Flu Trends, as a website open to the general public, has shut down. The Google Flu Trends team will continue to track flu patterns based on search history, but it will now provide that data directly to public health researchers at Columbia University’s Mailman School of Public Health, Boston Children’s Hospital, and the Centers for Disease Control and Prevention (CDC) Influenza Division....
By Jonah Comstock August 11, 2015
The old Dexcom Share, with charging cradle. DexCom has partnered with Google Life Sciences to develop the next generation of DexCom's CGM -- a device that is "the size of a dime", less expensive than current CGMs, and that the companies hope will eventually replace the fingerstick glucometer. The device is not just for people with Type 1 diabetes but also for those with Type 2 diabetes. "Our...
By Jonah Comstock July 16, 2015
MedWatcher, a tool for adverse event reporting, that the FDA worked on with Epidemico. Google met with the FDA last month to discuss the possibility of the FDA using Google search data to learn about drug side effects, according to a report in Bloomberg, which spotted a public record of the meeting and secured additional information from an FDA spokesperson. The talk appears to have been an...